William Soller, PhD, UCSF faculty member and expert on food and drug law and regulations comments on the June 30, 2009 vote of a US Food and Drug Administration (FDA) advisory committee to lower the US maximum over-the-counter dose of acetaminophen and make the current maximum single dose of the drug be available by prescription only. Soller's research on acetaminophen was included as part of the advisory committee's deliberations.

Full story

• FDA Crackdown on Acetaminophen [link defunct as of June 10, 2011]
• UCSF Clinical Pharmacy Study Is Part of FDA Acetaminophen Deliberations

More

• FDA Advises Lower Dosage for Popular Painkiller
• June 29-30, 2009: Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee Meeting Announcement
• Acetaminophen and Liver Injury: Q&A for Consumers